img

Global Chinese Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chinese Patent Medicine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Chinese Patent Medicine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Chinese Patent Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Chinese Patent Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Chinese Patent Medicine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Chinese Patent Medicine include Shanghai Pharmaceutical (Group) Co., Ltd., China Pharmaceutical Group Corporation, Guangzhou Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd, Nanjing Pharmaceutical Industry (Group) Co., Ltd., North China Pharmaceutical Group Co., Ltd., Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. and Taiji Group Co., Ltd., etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Chinese Patent Medicine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Chinese Patent Medicine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Chinese Patent Medicine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Chinese Patent Medicine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Shanghai Pharmaceutical (Group) Co., Ltd.
China Pharmaceutical Group Corporation
Guangzhou Pharmaceutical Group Co., Ltd.
Tianjin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd
Nanjing Pharmaceutical Industry (Group) Co., Ltd.
North China Pharmaceutical Group Co., Ltd.
Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
Taiji Group Co., Ltd.
Xinhualu Anti-Pharmaceutical Group Co., Ltd.
Nanjing Pharmaceutical Co., Ltd
Chongqing Pharmaceutical Co., Ltd
Hangzhou Huadong Pharmaceutical Group Co., Ltd.
Jiangxi Pharmaceutical Group Corporation
Shijiazhuang Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd.
By Type
Syrup
Liquid
Tablet
Others
By Application
Online Sales
Offline Sales
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Chinese Patent Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chinese Patent Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Chinese Patent Medicine Definition
1.2 Market by Type
1.2.1 Global Chinese Patent Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Syrup
1.2.3 Liquid
1.2.4 Tablet
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Chinese Patent Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Chinese Patent Medicine Sales
2.1 Global Chinese Patent Medicine Revenue Estimates and Forecasts 2018-2034
2.2 Global Chinese Patent Medicine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Chinese Patent Medicine Revenue by Region
2.3.1 Global Chinese Patent Medicine Revenue by Region (2018-2024)
2.3.2 Global Chinese Patent Medicine Revenue by Region (2024-2034)
2.4 Global Chinese Patent Medicine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Chinese Patent Medicine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Chinese Patent Medicine Sales Quantity by Region
2.6.1 Global Chinese Patent Medicine Sales Quantity by Region (2018-2024)
2.6.2 Global Chinese Patent Medicine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Chinese Patent Medicine Sales Quantity by Manufacturers
3.1.1 Global Chinese Patent Medicine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Chinese Patent Medicine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Sales in 2022
3.2 Global Chinese Patent Medicine Revenue by Manufacturers
3.2.1 Global Chinese Patent Medicine Revenue by Manufacturers (2018-2024)
3.2.2 Global Chinese Patent Medicine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Revenue in 2022
3.3 Global Chinese Patent Medicine Sales Price by Manufacturers
3.4 Global Key Players of Chinese Patent Medicine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Chinese Patent Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Chinese Patent Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Chinese Patent Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Chinese Patent Medicine Sales Quantity by Type
4.1.1 Global Chinese Patent Medicine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Chinese Patent Medicine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Chinese Patent Medicine Revenue by Type
4.2.1 Global Chinese Patent Medicine Historical Revenue by Type (2018-2024)
4.2.2 Global Chinese Patent Medicine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
4.3 Global Chinese Patent Medicine Price by Type
4.3.1 Global Chinese Patent Medicine Price by Type (2018-2024)
4.3.2 Global Chinese Patent Medicine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Chinese Patent Medicine Sales Quantity by Application
5.1.1 Global Chinese Patent Medicine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Chinese Patent Medicine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Chinese Patent Medicine Revenue by Application
5.2.1 Global Chinese Patent Medicine Historical Revenue by Application (2018-2024)
5.2.2 Global Chinese Patent Medicine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
5.3 Global Chinese Patent Medicine Price by Application
5.3.1 Global Chinese Patent Medicine Price by Application (2018-2024)
5.3.2 Global Chinese Patent Medicine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Chinese Patent Medicine Sales by Company
6.1.1 North America Chinese Patent Medicine Revenue by Company (2018-2024)
6.1.2 North America Chinese Patent Medicine Sales Quantity by Company (2018-2024)
6.2 North America Chinese Patent Medicine Market Size by Type
6.2.1 North America Chinese Patent Medicine Sales Quantity by Type (2018-2034)
6.2.2 North America Chinese Patent Medicine Revenue by Type (2018-2034)
6.3 North America Chinese Patent Medicine Market Size by Application
6.3.1 North America Chinese Patent Medicine Sales Quantity by Application (2018-2034)
6.3.2 North America Chinese Patent Medicine Revenue by Application (2018-2034)
6.4 North America Chinese Patent Medicine Market Size by Country
6.4.1 North America Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Chinese Patent Medicine Revenue by Country (2018-2034)
6.4.3 North America Chinese Patent Medicine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Chinese Patent Medicine Sales by Company
7.1.1 Europe Chinese Patent Medicine Sales Quantity by Company (2018-2024)
7.1.2 Europe Chinese Patent Medicine Revenue by Company (2018-2024)
7.2 Europe Chinese Patent Medicine Market Size by Type
7.2.1 Europe Chinese Patent Medicine Sales Quantity by Type (2018-2034)
7.2.2 Europe Chinese Patent Medicine Revenue by Type (2018-2034)
7.3 Europe Chinese Patent Medicine Market Size by Application
7.3.1 Europe Chinese Patent Medicine Sales Quantity by Application (2018-2034)
7.3.2 Europe Chinese Patent Medicine Revenue by Application (2018-2034)
7.4 Europe Chinese Patent Medicine Market Size by Country
7.4.1 Europe Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Chinese Patent Medicine Revenue by Country (2018-2034)
7.4.3 Europe Chinese Patent Medicine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Chinese Patent Medicine Sales by Company
8.1.1 China Chinese Patent Medicine Sales Quantity by Company (2018-2024)
8.1.2 China Chinese Patent Medicine Revenue by Company (2018-2024)
8.2 China Chinese Patent Medicine Market Size by Type
8.2.1 China Chinese Patent Medicine Sales Quantity by Type (2018-2034)
8.2.2 China Chinese Patent Medicine Revenue by Type (2018-2034)
8.3 China Chinese Patent Medicine Market Size by Application
8.3.1 China Chinese Patent Medicine Sales Quantity by Application (2018-2034)
8.3.2 China Chinese Patent Medicine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Chinese Patent Medicine Sales by Company
9.1.1 APAC Chinese Patent Medicine Sales Quantity by Company (2018-2024)
9.1.2 APAC Chinese Patent Medicine Revenue by Company (2018-2024)
9.2 APAC Chinese Patent Medicine Market Size by Type
9.2.1 APAC Chinese Patent Medicine Sales Quantity by Type (2018-2034)
9.2.2 APAC Chinese Patent Medicine Revenue by Type (2018-2034)
9.3 APAC Chinese Patent Medicine Market Size by Application
9.3.1 APAC Chinese Patent Medicine Sales Quantity by Application (2018-2034)
9.3.2 APAC Chinese Patent Medicine Revenue by Application (2018-2034)
9.4 APAC Chinese Patent Medicine Market Size by Region
9.4.1 APAC Chinese Patent Medicine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Chinese Patent Medicine Revenue by Region (2018-2034)
9.4.3 APAC Chinese Patent Medicine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Chinese Patent Medicine Sales by Company
10.1.1 Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Chinese Patent Medicine Market Size by Type
10.2.1 Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Chinese Patent Medicine Market Size by Application
10.3.1 Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Chinese Patent Medicine Market Size by Country
10.4.1 Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Shanghai Pharmaceutical (Group) Co., Ltd.
11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Overview
11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products and Services
11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.1.6 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
11.2 China Pharmaceutical Group Corporation
11.2.1 China Pharmaceutical Group Corporation Company Information
11.2.2 China Pharmaceutical Group Corporation Overview
11.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Products and Services
11.2.5 China Pharmaceutical Group Corporation Chinese Patent Medicine SWOT Analysis
11.2.6 China Pharmaceutical Group Corporation Recent Developments
11.3 Guangzhou Pharmaceutical Group Co., Ltd.
11.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Company Information
11.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Overview
11.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.3.6 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
11.4 Tianjin Pharmaceutical Group Co., Ltd.
11.4.1 Tianjin Pharmaceutical Group Co., Ltd. Company Information
11.4.2 Tianjin Pharmaceutical Group Co., Ltd. Overview
11.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.4.5 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.4.6 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
11.5 Harbin Pharmaceutical Group Co., Ltd
11.5.1 Harbin Pharmaceutical Group Co., Ltd Company Information
11.5.2 Harbin Pharmaceutical Group Co., Ltd Overview
11.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Products and Services
11.5.5 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine SWOT Analysis
11.5.6 Harbin Pharmaceutical Group Co., Ltd Recent Developments
11.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
11.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
11.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Overview
11.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Products and Services
11.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.6.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
11.7 North China Pharmaceutical Group Co., Ltd.
11.7.1 North China Pharmaceutical Group Co., Ltd. Company Information
11.7.2 North China Pharmaceutical Group Co., Ltd. Overview
11.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.7.5 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.7.6 North China Pharmaceutical Group Co., Ltd. Recent Developments
11.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
11.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
11.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Overview
11.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.8.6 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
11.9 Taiji Group Co., Ltd.
11.9.1 Taiji Group Co., Ltd. Company Information
11.9.2 Taiji Group Co., Ltd. Overview
11.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Products and Services
11.9.5 Taiji Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.9.6 Taiji Group Co., Ltd. Recent Developments
11.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
11.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
11.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Overview
11.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
11.10.6 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
11.11 Nanjing Pharmaceutical Co., Ltd
11.11.1 Nanjing Pharmaceutical Co., Ltd Company Information
11.11.2 Nanjing Pharmaceutical Co., Ltd Overview
11.11.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Products and Services
11.11.5 Nanjing Pharmaceutical Co., Ltd Recent Developments
11.12 Chongqing Pharmaceutical Co., Ltd
11.12.1 Chongqing Pharmaceutical Co., Ltd Company Information
11.12.2 Chongqing Pharmaceutical Co., Ltd Overview
11.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Products and Services
11.12.5 Chongqing Pharmaceutical Co., Ltd Recent Developments
11.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
11.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
11.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Overview
11.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
11.14 Jiangxi Pharmaceutical Group Corporation
11.14.1 Jiangxi Pharmaceutical Group Corporation Company Information
11.14.2 Jiangxi Pharmaceutical Group Corporation Overview
11.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Products and Services
11.14.5 Jiangxi Pharmaceutical Group Corporation Recent Developments
11.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
11.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
11.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Overview
11.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
11.16 Northeast Pharmaceutical Group Co., Ltd.
11.16.1 Northeast Pharmaceutical Group Co., Ltd. Company Information
11.16.2 Northeast Pharmaceutical Group Co., Ltd. Overview
11.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products and Services
11.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Chinese Patent Medicine Value Chain Analysis
12.2 Chinese Patent Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chinese Patent Medicine Production Mode & Process
12.4 Chinese Patent Medicine Sales and Marketing
12.4.1 Chinese Patent Medicine Sales Channels
12.4.2 Chinese Patent Medicine Distributors
12.5 Chinese Patent Medicine Customers
13 Market Dynamics
13.1 Chinese Patent Medicine Industry Trends
13.2 Chinese Patent Medicine Market Drivers
13.3 Chinese Patent Medicine Market Challenges
13.4 Chinese Patent Medicine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Chinese Patent Medicine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Syrup
Table 3. Major Manufacturers of Liquid
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Others
Table 6. Global Chinese Patent Medicine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Chinese Patent Medicine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Chinese Patent Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Chinese Patent Medicine Revenue Market Share by Region (2018-2024)
Table 10. Global Chinese Patent Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Chinese Patent Medicine Revenue Market Share by Region (2024-2034)
Table 12. Global Chinese Patent Medicine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 13. Global Chinese Patent Medicine Sales by Region (2018-2024) & (K MT)
Table 14. Global Chinese Patent Medicine Sales Market Share by Region (2018-2024)
Table 15. Global Chinese Patent Medicine Sales by Region (2024-2034) & (K MT)
Table 16. Global Chinese Patent Medicine Sales Market Share by Region (2024-2034)
Table 17. Global Chinese Patent Medicine Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 18. Global Chinese Patent Medicine Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Chinese Patent Medicine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Chinese Patent Medicine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Chinese Patent Medicine Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Key Players of Chinese Patent Medicine, Industry Ranking, 2021 VS 2022
Table 23. Global Chinese Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2022)
Table 25. Global Key Manufacturers of Chinese Patent Medicine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Chinese Patent Medicine, Product Offered and Application
Table 27. Global Key Manufacturers of Chinese Patent Medicine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 30. Global Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 31. Global Chinese Patent Medicine Sales Quantity Share by Type (2018-2024)
Table 32. Global Chinese Patent Medicine Sales Quantity Share by Type (2024-2034)
Table 33. Global Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Chinese Patent Medicine Revenue Share by Type (2018-2024)
Table 36. Global Chinese Patent Medicine Revenue Share by Type (2024-2034)
Table 37. Chinese Patent Medicine Price by Type (2018-2024) & (USD/MT)
Table 38. Global Chinese Patent Medicine Price Forecast by Type (2024-2034) & (USD/MT)
Table 39. Global Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 40. Global Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 41. Global Chinese Patent Medicine Sales Quantity Share by Application (2018-2024)
Table 42. Global Chinese Patent Medicine Sales Quantity Share by Application (2024-2034)
Table 43. Global Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Chinese Patent Medicine Revenue Share by Application (2018-2024)
Table 46. Global Chinese Patent Medicine Revenue Share by Application (2024-2034)
Table 47. Chinese Patent Medicine Price by Application (2018-2024) & (USD/MT)
Table 48. Global Chinese Patent Medicine Price Forecast by Application (2024-2034) & (USD/MT)
Table 49. North America Chinese Patent Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Chinese Patent Medicine Sales Quantity by Company (2018-2024) & (K MT)
Table 51. North America Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 52. North America Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 53. North America Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 56. North America Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 57. North America Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Chinese Patent Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Chinese Patent Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Chinese Patent Medicine Sales Quantity by Country (2018-2024) & (K MT)
Table 63. North America Chinese Patent Medicine Sales Quantity by Country (2024-2034) & (K MT)
Table 64. Europe Chinese Patent Medicine Sales Quantity by Company (2018-2024) & (K MT)
Table 65. Europe Chinese Patent Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 67. Europe Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 68. Europe Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 71. Europe Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 72. Europe Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Chinese Patent Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Chinese Patent Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Chinese Patent Medicine Sales Quantity by Country (2018-2024) & (K MT)
Table 78. Europe Chinese Patent Medicine Sales Quantity by Country (2024-2034) & (K MT)
Table 79. China Chinese Patent Medicine Sales Quantity by Company (2018-2024) & (K MT)
Table 80. China Chinese Patent Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 82. China Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 83. China Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 86. China Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 87. China Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Chinese Patent Medicine Sales Quantity by Company (2018-2024) & (K MT)
Table 90. APAC Chinese Patent Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 92. APAC Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 93. APAC Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 96. APAC Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 97. APAC Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Chinese Patent Medicine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Chinese Patent Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Chinese Patent Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Chinese Patent Medicine Sales Quantity by Region (2018-2024) & (K MT)
Table 103. APAC Chinese Patent Medicine Sales Quantity by Region (2024-2034) & (K MT)
Table 104. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Company (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Type (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Type (2024-2034) & (K MT)
Table 108. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Application (2018-2024) & (K MT)
Table 111. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Application (2024-2034) & (K MT)
Table 112. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Chinese Patent Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Country (2018-2024) & (K MT)
Table 118. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity by Country (2024-2034) & (K MT)
Table 119. Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
Table 120. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Overview
Table 121. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 122. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product and Services
Table 123. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 124. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
Table 125. China Pharmaceutical Group Corporation Company Information
Table 126. China Pharmaceutical Group Corporation Description and Overview
Table 127. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 128. China Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
Table 129. China Pharmaceutical Group Corporation Chinese Patent Medicine SWOT Analysis
Table 130. China Pharmaceutical Group Corporation Recent Developments
Table 131. Guangzhou Pharmaceutical Group Co., Ltd. Company Information
Table 132. Guangzhou Pharmaceutical Group Co., Ltd. Description and Overview
Table 133. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 134. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 135. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 136. Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
Table 137. Tianjin Pharmaceutical Group Co., Ltd. Company Information
Table 138. Tianjin Pharmaceutical Group Co., Ltd. Description and Overview
Table 139. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 140. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 141. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 142. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
Table 143. Harbin Pharmaceutical Group Co., Ltd Company Information
Table 144. Harbin Pharmaceutical Group Co., Ltd Description and Overview
Table 145. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 146. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product and Services
Table 147. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine SWOT Analysis
Table 148. Harbin Pharmaceutical Group Co., Ltd Recent Developments
Table 149. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
Table 150. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Overview
Table 151. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 152. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product and Services
Table 153. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 154. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
Table 155. North China Pharmaceutical Group Co., Ltd. Company Information
Table 156. North China Pharmaceutical Group Co., Ltd. Description and Overview
Table 157. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 158. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 159. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 160. North China Pharmaceutical Group Co., Ltd. Recent Developments
Table 161. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
Table 162. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Overview
Table 163. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 164. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 165. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 166. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
Table 167. Taiji Group Co., Ltd. Company Information
Table 168. Taiji Group Co., Ltd. Description and Overview
Table 169. Taiji Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 170. Taiji Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 171. Taiji Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 172. Taiji Group Co., Ltd. Recent Developments
Table 173. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
Table 174. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Overview
Table 175. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 176. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 177. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine SWOT Analysis
Table 178. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
Table 179. Nanjing Pharmaceutical Co., Ltd Company Information
Table 180. Nanjing Pharmaceutical Co., Ltd Description and Overview
Table 181. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 182. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
Table 183. Nanjing Pharmaceutical Co., Ltd Recent Developments
Table 184. Chongqing Pharmaceutical Co., Ltd Company Information
Table 185. Chongqing Pharmaceutical Co., Ltd Description and Overview
Table 186. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 187. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product and Services
Table 188. Chongqing Pharmaceutical Co., Ltd Recent Developments
Table 189. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
Table 190. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Overview
Table 191. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 192. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 193. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
Table 194. Jiangxi Pharmaceutical Group Corporation Company Information
Table 195. Jiangxi Pharmaceutical Group Corporation Description and Overview
Table 196. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 197. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product and Services
Table 198. Jiangxi Pharmaceutical Group Corporation Recent Developments
Table 199. Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
Table 200. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Overview
Table 201. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 202. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 203. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
Table 204. Northeast Pharmaceutical Group Co., Ltd. Company Information
Table 205. Northeast Pharmaceutical Group Co., Ltd. Description and Overview
Table 206. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 207. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product and Services
Table 208. Northeast Pharmaceutical Group Co., Ltd. Recent Developments
Table 209. Key Raw Materials Lists
Table 210. Raw Materials Key Suppliers Lists
Table 211. Chinese Patent Medicine Distributors List
Table 212. Chinese Patent Medicine Customers List
Table 213. Chinese Patent Medicine Market Trends
Table 214. Chinese Patent Medicine Market Drivers
Table 215. Chinese Patent Medicine Market Challenges
Table 216. Chinese Patent Medicine Market Restraints
Table 217. Research Programs/Design for This Report
Table 218. Key Data Information from Secondary Sources
Table 219. Key Data Information from Primary Sources
List of Figures
Figure 1. Chinese Patent Medicine Product Picture
Figure 2. Global Chinese Patent Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Chinese Patent Medicine Market Share by Type in 2022 & 2034
Figure 4. Syrup Product Picture
Figure 5. Liquid Product Picture
Figure 6. Tablet Product Picture
Figure 7. Others Product Picture
Figure 8. Global Chinese Patent Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Chinese Patent Medicine Market Share by Application in 2022 & 2034
Figure 10. Online Sales
Figure 11. Offline Sales
Figure 12. Chinese Patent Medicine Report Years Considered
Figure 13. Global Chinese Patent Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Chinese Patent Medicine Revenue 2018-2034 (US$ Million)
Figure 15. Global Chinese Patent Medicine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Chinese Patent Medicine Sales Quantity 2018-2034 (K MT)
Figure 17. Global Chinese Patent Medicine Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Chinese Patent Medicine Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Chinese Patent Medicine Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. North America Chinese Patent Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Chinese Patent Medicine Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. Europe Chinese Patent Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Chinese Patent Medicine Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. China Chinese Patent Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Chinese Patent Medicine Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. APAC Chinese Patent Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. Middle East, Africa and Latin America Chinese Patent Medicine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Chinese Patent Medicine Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Chinese Patent Medicine Revenue in 2022
Figure 31. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 34. Global Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 36. North America Chinese Patent Medicine Revenue Market Share by Company in 2022
Figure 37. North America Chinese Patent Medicine Sales Quantity Market Share by Company in 2022
Figure 38. North America Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 40. North America Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 42. North America Chinese Patent Medicine Revenue Share by Country (2018-2034)
Figure 43. North America Chinese Patent Medicine Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Chinese Patent Medicine Sales Quantity Market Share by Company in 2022
Figure 47. Europe Chinese Patent Medicine Revenue Market Share by Company in 2022
Figure 48. Europe Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 50. Europe Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 52. Europe Chinese Patent Medicine Revenue Share by Country (2018-2034)
Figure 53. Europe Chinese Patent Medicine Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 55. France Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 59. China Chinese Patent Medicine Sales Quantity Market Share by Company in 2022
Figure 60. China Chinese Patent Medicine Revenue Market Share by Company in 2022
Figure 61. China Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 63. China Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 65. APAC Chinese Patent Medicine Sales Quantity Market Share by Company in 2022
Figure 66. APAC Chinese Patent Medicine Revenue Market Share by Company in 2022
Figure 67. APAC Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 69. APAC Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 71. APAC Chinese Patent Medicine Revenue Share by Region (2018-2034)
Figure 72. APAC Chinese Patent Medicine Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 77. India Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Chinese Patent Medicine Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Chinese Patent Medicine Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Chinese Patent Medicine Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Chinese Patent Medicine Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Chinese Patent Medicine Revenue Share by Country (2018-2034)
Figure 86. Brazil Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Chinese Patent Medicine Revenue (2018-2034) & (US$ Million)
Figure 91. Chinese Patent Medicine Value Chain
Figure 92. Chinese Patent Medicine Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed